February 21, 2025
Tag: Clinical Research Program
February 21, 2025
Medscape: Bladder Cancer Survival Better With Nivolumab Than Placebo in New Analysis
February 17, 2025
MedPage Today: Adjuvant Nivolumab Boosts Survival Outcomes in Muscle-Invasive Bladder Cancer
February 17, 2025
CURE: Adjuvant Opdivo Continues to Provide Survival Benefit in Patients With High-Risk MIUC
February 14, 2025
Study now recruiting patients to treat PANcreatic adenocarcinoma with Gemcitabine, Erlotinib, and nAb-paclitaxel (PANGEA)
UNC Lineberger has opened a two-arm clinical trial to determine the optimal combination treatment for patients with advanced unresectable or metastatic basal-like subtype pancreatic ductal adenocarcinoma.
February 14, 2025
CancerNetwork: Adjuvant Nivolumab Shows Sustained DFS Benefit in High-Risk Bladder Cancer
February 14, 2025
OncLive: Updated CheckMate-274 Data Further Support Adjuvant Nivolumab as SOC for High-Risk MIUC
February 13, 2025
Malawi cancer program develops diagnostic breakthrough
Part of UNC Project Malawi, the cancer program provides clinical care, pathology training and other services to the African nation. The program is entering the second phase of developing a low-cost cancer diagnosis method.
January 28, 2025
UNC Lineberger hosts NCI in gastrointestinal cancer SPORE Investigators Meeting
The nation’s top gastrointestinal cancer clinical translational researchers convened in Chapel Hill for the 2025 GI SPORE Investigators Meeting.
December 11, 2024